Xenon Pharmaceuticals Inc. (XENE)

CIK 1582313 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Xenon Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 202640001193125-26-382412
Aug 31, 202640001193125-26-377309
Aug 28, 20261440001950047-26-008816
Aug 13, 2026SCHEDULE 13G/A0000902219-26-000248
Aug 13, 202640001193125-26-349351
Aug 13, 20261440001193125-26-349336
Aug 7, 2026SCHEDULE 13G/A0000315066-26-002245
Aug 6, 20268-K0001193125-26-338019
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002171
Aug 6, 202610-Q0001193125-26-338244
Jun 8, 202640001193125-26-262672
Jun 8, 202640001193125-26-262671
Jun 5, 20261440001950047-26-005712
Jun 5, 20261440001950047-26-005710
Jun 3, 202640001193125-26-256124
Jun 3, 202640001193125-26-256125
Jun 3, 2026S-8 POS0001193125-26-255544
Jun 3, 202640001193125-26-256126
Jun 3, 2026S-8 POS0001193125-26-255452
Jun 3, 2026S-8 POS0001193125-26-255530
Jun 3, 202640001193125-26-256121
Jun 3, 2026S-8 POS0001193125-26-255539
Jun 3, 2026S-8 POS0001193125-26-255442
Jun 3, 2026S-8 POS0001193125-26-255486
Jun 3, 202640001193125-26-256120